Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ramanand SG"'
Autor:
Yuan J; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Houlahan KE; Department of Human Genetics, University of California, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Vector Institute, Toronto, Ontario, Canada.; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas., Lee S; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas., Baek G; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas., Yang Y; The Province and Ministry Cosponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Key Laboratory of Inflammation Biology, Department of Bioinformatics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.; Department of Geriatrics, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China., Chen Y; Department of Molecular and Cellular Biosciences, Rowan University, Glassboro, New Jersey., Strand DW; Department of Urology, UT Southwestern Medical Center, Dallas, Texas., Zhang MQ; Department of Biological Sciences, Center for Systems Biology, The University of Texas at Dallas, Richardson, Texas.; MOE Key Laboratory of Bioinformatics and Bioinformatics Division, Center for Synthetic and System Biology, TNLIST/Department Automation, Tsinghua University, Beijing, China., Boutros PC; Department of Human Genetics, University of California, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Vector Institute, Toronto, Ontario, Canada.; Department of Urology, University of California, Los Angeles, California.; Institute for Precision Health, University of California, Los Angeles, California., Mani RS; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas.; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Dec 02; Vol. 12 (12), pp. 2838-2855.
Autor:
Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Mani RS; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: ram.mani@utsouthwestern.edu.
Publikováno v:
Molecular cell [Mol Cell] 2022 Aug 04; Vol. 82 (15), pp. 2730-2731.
Autor:
Sahoo SS; Department of Pathology., Ramanand SG; Department of Pathology., Gao Y; Department of Pathology., Abbas A; Department of Pathology., Kumar A; Eugene McDermott Center for Human Growth and Development., Cuevas IC; Department of Pathology., Li HD; Department of Pathology., Aguilar M; Department of Pathology., Xing C; Eugene McDermott Center for Human Growth and Development.; Department of Bioinformatics.; Department of Population and Data Sciences., Mani RS; Department of Pathology.; Harold C. Simmons Comprehensive Cancer Center.; Department of Urology, and., Castrillon DH; Department of Pathology.; Harold C. Simmons Comprehensive Cancer Center.; Department of Obstetrics and Gynecology, UT Southwestern Medical Center, Dallas, Texas, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2022 Jun 15; Vol. 132 (12).
Autor:
Mehta RK; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Shukla S; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA., Somnay V; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Bridges AJ; School of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA., Lawrence TS; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Nyati MK; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: nyati@umich.edu.
Publikováno v:
Translational oncology [Transl Oncol] 2021 Aug; Vol. 14 (8), pp. 101140. Date of Electronic Publication: 2021 Jun 06.
Autor:
Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA., Chen Y; Department of Biological Sciences, Center for Systems Biology, University of Texas at Dallas, Richardson, Texas, USA.; Department of Molecular and Cellular Biosciences, Rowan University, Glassboro, New Jersey, USA., Yuan J; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA., Daescu K; Department of Biological Sciences, Center for Systems Biology, University of Texas at Dallas, Richardson, Texas, USA., Lambros MB; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research (ICR) and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Houlahan KE; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Vector Institute, Toronto, Ontario, Canada.; Department of Urology.; Department of Human Genetics, and.; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, USA., Carreira S; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research (ICR) and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Yuan W; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research (ICR) and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Baek G; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA., Sharp A; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research (ICR) and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Paschalis A; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research (ICR) and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Kanchwala M; Eugene McDermott Center for Human Growth and Development., Gao Y; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA., Aslam A; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA., Safdar N; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA., Zhan X; Department of Population and Data Sciences., Raj GV; Department of Urology, and., Xing C; Department of Urology.; Department of Human Genetics, and.; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, Texas, USA., Boutros PC; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Vector Institute, Toronto, Ontario, Canada.; Department of Urology.; Department of Human Genetics, and.; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, USA., de Bono J; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research (ICR) and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Zhang MQ; Department of Biological Sciences, Center for Systems Biology, University of Texas at Dallas, Richardson, Texas, USA.; MOE Key Laboratory of Bioinformatics and Bioinformatics Division, Center for Synthetic and Systems Biology, TNLIST/Department of Automation, Tsinghua University, Beijing, China., Mani RS; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.; Department of Urology, and.; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 Aug 03; Vol. 130 (8), pp. 3987-4005.
Autor:
Houlahan KE; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Vector Institute, Toronto, Ontario, Canada., Shiah YJ; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Gusev A; Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Yuan J; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA., Ahmed M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Shetty A; Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; University of Cambridge, Cambridge, UK., Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA., Yao CQ; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., O'Connor E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Huang V; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Fraser M; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Heisler LE; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Livingstone J; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Yamaguchi TN; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Rouette A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Foucal A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Espiritu SMG; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Sinha A; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Sam M; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Timms L; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Johns J; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Wong A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Murison A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Orain M; Department of Pathology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada., Picard V; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada., Hovington H; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada., Bergeron A; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada., Lacombe L; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada., Lupien M; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Fradet Y; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada., Têtu B; Department of Pathology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada., McPherson JD; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Pasaniuc B; Department of Computational Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA., Kislinger T; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Chua MLK; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., van der Kwast T; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Mani RS; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA., He HH; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Bristow RG; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. robert.bristow@manchester.ac.uk.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. robert.bristow@manchester.ac.uk.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. robert.bristow@manchester.ac.uk.; Division of Cancer Sciences, Faculty of Biology, Health and Medicine, University of Manchester, Manchester, UK. robert.bristow@manchester.ac.uk.; The Christie NHS Foundation Trust, Manchester, UK. robert.bristow@manchester.ac.uk.; Cancer Research UK Manchester Institute, Manchester, UK. robert.bristow@manchester.ac.uk.; Manchester Cancer Research Centre, Manchester, UK. robert.bristow@manchester.ac.uk., Boutros PC; Ontario Institute for Cancer Research, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.; Vector Institute, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.; Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.
Publikováno v:
Nature medicine [Nat Med] 2019 Oct; Vol. 25 (10), pp. 1615-1626. Date of Electronic Publication: 2019 Oct 07.
Autor:
Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA., Mani RS; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. ram.mani@utsouthwestern.edu.; Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA. ram.mani@utsouthwestern.edu.; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. ram.mani@utsouthwestern.edu.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2019; Vol. 1210, pp. 57-66.
Autor:
Li X; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Baek G; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Sharp A; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Gao Y; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Yuan W; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Welti J; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Rodrigues DN; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Dolling D; Clinical Trials and Statistics Unit, Institute of Cancer Research, London SM2 5NG, UK., Figueiredo I; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Sumanasuriya S; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Crespo M; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Aslam A; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Li R; Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Yin Y; Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Mukherjee B; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Kanchwala M; Eugene McDermott Center for Human Growth & Development, UT Southwestern Medical Center, Dallas, TX 75390, USA., Hughes AM; Target Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., Halsey WS; Target Sciences, GlaxoSmithKline, Collegeville, PA 19426, USA., Chiang CM; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Biochemistry, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Xing C; Eugene McDermott Center for Human Growth & Development, UT Southwestern Medical Center, Dallas, TX 75390, USA., Raj GV; Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390, USA., Burma S; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX 75390, USA., de Bono J; Prostate Cancer Targeted Therapy and Cancer Biomarkers Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK., Mani RS; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: ram.mani@utsouthwestern.edu.
Publikováno v:
Cell reports [Cell Rep] 2018 Jan 16; Vol. 22 (3), pp. 796-808.
Autor:
Yin Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas. Yi.Yin@utsouthwestern.edu Ganesh.Raj@utsouthwestern.edu., Li R; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Xu K; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Ding S; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, P.R. China., Li J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Baek G; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Ramanand SG; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Ding S; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Liu Z; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, P.R. China., Gao Y; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Kanchwala MS; Eugene McDermott Center for Human Growth & Development, University of Texas Southwestern Medical Center, Dallas, Texas., Li X; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Hutchinson R; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Liu X; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Woldu SL; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas., Xing C; Eugene McDermott Center for Human Growth & Development, University of Texas Southwestern Medical Center, Dallas, Texas., Desai NB; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Feng FY; Department of Radiation Oncology, University of California at San Francisco, San Francisco, California.; Department of Urology, University of California at San Francisco, San Francisco, California.; Department of Medicine, University of California at San Francisco, San Francisco, California., Burma S; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., de Bono JS; Drug Development Unit and Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, United Kingdom., Dehm SM; Masonic Cancer Center and Departments of Laboratory Medicine and Pathology and Urology, University of Minnesota, Minneapolis, Minnesota., Mani RS; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas., Chen BPC; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Raj GV; Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas. Yi.Yin@utsouthwestern.edu Ganesh.Raj@utsouthwestern.edu.; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas.
Publikováno v:
Cancer research [Cancer Res] 2017 Sep 15; Vol. 77 (18), pp. 4745-4754. Date of Electronic Publication: 2017 Jul 28.
Autor:
Mani RS; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75235, USA; Department of Urology, UT Southwestern Medical Center, Dallas, TX 75235, USA; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75235, USA. Electronic address: ram.mani@utsouthwestern.edu., Amin MA; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Li X; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75235, USA., Kalyana-Sundaram S; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Veeneman BA; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA., Wang L; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Ghosh A; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Aslam A; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75235, USA., Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75235, USA., Rabquer BJ; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Kimura W; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA; Life Science Center, Tsukuba Advanced Research Alliance, University of Tsukuba, Ibaraki 305-8577, Japan., Tran M; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Cao X; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Roychowdhury S; Department of Internal Medicine, The James Cancer Center, Ohio State University, Columbus, OH 43210, USA., Dhanasekaran SM; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Palanisamy N; Department of Urology, Henry Ford Health System, Detroit, MI 48202, USA., Sadek HA; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75235, USA., Kapur P; Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75235, USA; Department of Urology, UT Southwestern Medical Center, Dallas, TX 75235, USA., Koch AE; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA; VA Ann Arbor, Ann Arbor, MI 48105, USA., Chinnaiyan AM; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: arul@umich.edu.
Publikováno v:
Cell reports [Cell Rep] 2016 Dec 06; Vol. 17 (10), pp. 2620-2631.